Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of tDCS on Cognition, Symptoms in Chronic Schizophrenia Patients With Tardive dyskinesia_a Randomized, Double-blind, Sham-controlled Trial

NCT03497013 is registered in ClinicalTrials.gov with Suzhou Psychiatric Hospital as lead sponsor.

NCT NCT03497013
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03497013 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of tDCS on Cognition, Symptoms in Chronic Schizophrenia Patients With Tardive dyskinesia_a Randomized, Double-blind, Sham-controlled Trial
Lead sponsor
Suzhou Psychiatric Hospital
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2017
Completion date
August 11, 2020
Enrollment
64 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

tardive dyskinesia